2003

Solid Oral UF Heparin



• Secure partnership;
• Publication of Phase III “PROTECT” Trial in peer reviewed journal

• Oral Insulin: secure partnership

• Oral PTH: Phase I data with Lilly

• Oral rhGH: Phase I data with Lilly

• Oral Cromolyn: Additional data

Oral Salmon Calcitonin

• Phase II data with Novartis;
• initiate additional studies

Feasibility candidates

• Advance from feasibility to POC stage;
• Partner

Upcoming Milestones

Previous slide

Next slide

Back to first slide

View graphic version